Skip to content

Study · Case report or series · n = 1 · 2026

1 result

Non-Arteritic Ischaemic Optic Neuropathy Associated with Semaglutide Use.

Kelly A, Hasif A, McAnena L, O'Brien C

Irish medical journal22 Jan 2026

PMID41589628 (opens in a new tab)PepBankPUB-41589628

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanCase report or seriesSafety outcome

    In a 50-year-old obese man with non-insulin dependent diabetes taking semaglutide, sudden painless vision loss in the right eye was diagnosed as non-arteritic anterior ischaemic optic neuropathy.

    In plain wordsOne man taking semaglutide lost vision suddenly in one eye from optic nerve damage. One case cannot show cause.

    Outcome
    Not applicableNon-arteritic anterior ischaemic optic neuropathy
    Study

    n = 1

    Outcome group
    Adverse events · Eye
    Studied dose
    Dose not stated

    Source sentences

    Summary
    A 50-year-old obese male with non-insulin dependent diabetes mellitus (NIDDM) taking Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA) presented with sudden, painless vision-loss from his right eye.
    1 context sentence
    Summary · context
    The patient was diagnosed with non-arteritic anterior ischaemic optic neuropathy.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 00:04 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:06 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.